Literature DB >> 22461172

Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.

Kyung-Ok Kim1, Erik R Sampson, Robert D Maynard, Regis J O'Keefe, Di Chen, Hicham Drissi, Randy N Rosier, Matthew J Hilton, Michael J Zuscik.   

Abstract

Since transforming growing factor-β (TGF-β)/Smad signaling inhibits chondrocyte maturation, endogenous negative regulators of TGF-β signaling are likely also important regulators of the chondrocyte differentiation process. One such negative regulator, Ski, is an oncoprotein that is known to inhibit TGF-β/Smad3 signaling via its interaction with phospho-Smad3 and recruitment of histone deacetylases (HDACs) to the DNA binding complex. Based on this, we hypothesized that Ski inhibits TGF-β signaling and accelerates maturation in chondrocytes via recruitment of HDACs to transcriptional complexes containing Smads. We tested this hypothesis in chick upper sternal chondrocytes (USCs), where gain and loss of Ski expression experiments were performed. Over-expression of Ski not only reversed the inhibitory effect of TGF-β on the expression of hypertrophic marker genes such as type X collagen (colX) and osteocalcin, it induced these genes basally as well. Conversely, knockdown of Ski by RNA interference led to a reduction of colX and osteocalcin expression under basal conditions. Furthermore, Ski blocked TGF-β induction of cyclinD1 and caused a basal up-regulation of Runx2, consistent with the observed acceleration of hypertrophy. Regarding mechanism, not only does Ski associate with phospho-Smad2 and 3, but its association with phospho-Smad3 is required for recruitment of HDAC4 and 5. Implicating this recruitment of HDACs in the phenotypic effects of Ski in chondrocytes, the HDAC inhibitor SAHA reversed the up-regulation of colX and osteocalcin in Ski over-expressing cells. These results suggest that inhibition of TGF-β signaling by Ski, which involves its association with phospho-Smad3 and recruitment of HDAC4 and 5, leads to accelerated chondrocyte differentiation.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22461172      PMCID: PMC3324639          DOI: 10.1002/jcb.24089

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  65 in total

1.  ATF-2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation.

Authors:  Andreia M Ionescu; Edward M Schwarz; Michael J Zuscik; Hicham Drissi; J Edward Puzas; Randy N Rosier; Regis J O'Keefe
Journal:  Exp Cell Res       Date:  2003-08-01       Impact factor: 3.905

Review 2.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

3.  The Ski protein family is required for MeCP2-mediated transcriptional repression.

Authors:  K Kokura; S C Kaul; R Wadhwa; T Nomura; M M Khan; T Shinagawa; T Yasukawa; C Colmenares; S Ishii
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

4.  Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.

Authors:  Run Shen; Mo Chen; Yong-Jun Wang; Hiroyuki Kaneki; Lianping Xing; Regis J O'keefe; Di Chen
Journal:  J Biol Chem       Date:  2005-11-18       Impact factor: 5.157

5.  Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.

Authors:  Jong Seok Kang; Tamara Alliston; Rachel Delston; Rik Derynck
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

Review 6.  Ski/Sno and TGF-beta signaling.

Authors:  X Liu; Y Sun; R A Weinberg; H F Lodish
Journal:  Cytokine Growth Factor Rev       Date:  2001-03       Impact factor: 7.638

Review 7.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

8.  Protooncogene c-ski is expressed in both proliferating and postmitotic neuronal populations.

Authors:  G E Lyons; B K Micales; M J Herr; S K Horrigan; S Namciu; D Shardy; E Stavnezer
Journal:  Dev Dyn       Date:  1994-12       Impact factor: 3.780

9.  ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development.

Authors:  Donghui Zhang; Edward M Schwarz; Randy N Rosier; Michael J Zuscik; J Edward Puzas; Regis J O'Keefe
Journal:  J Bone Miner Res       Date:  2003-09       Impact factor: 6.741

10.  Negative regulation of BMP signaling by the ski oncoprotein.

Authors:  Kunxin Luo
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

View more
  16 in total

Review 1.  Histone Deacetylases in Bone Development and Skeletal Disorders.

Authors:  Elizabeth W Bradley; Lomeli R Carpio; Andre J van Wijnen; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

2.  c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion.

Authors:  Liyang Wang; Yixuan Hou; Yan Sun; Liuyang Zhao; Xi Tang; Ping Hu; Jiajia Yang; Zongyue Zeng; Guanglun Yang; Xiaojiang Cui; Manran Liu
Journal:  Mol Oncol       Date:  2013-08-27       Impact factor: 6.603

Review 3.  TGFβ/BMP Signaling Pathway in Cartilage Homeostasis.

Authors:  Nathalie G M Thielen; Peter M van der Kraan; Arjan P M van Caam
Journal:  Cells       Date:  2019-08-24       Impact factor: 6.600

4.  SKI knockdown suppresses apoptosis and extracellular matrix degradation of nucleus pulposus cells via inhibition of the Wnt/β-catenin pathway and ameliorates disc degeneration.

Authors:  Zuo-Long Wu; Ya-Jun Chen; Guang-Zhi Zhang; Qi-Qi Xie; Ke-Ping Wang; Xin Yang; Tai-Cong Liu; Zhi-Qiang Wang; Guang-Hai Zhao; Hai-Hong Zhang
Journal:  Apoptosis       Date:  2022-02-11       Impact factor: 4.677

5.  In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome.

Authors:  Virginie Carmignac; Julien Thevenon; Lesley Adès; Bert Callewaert; Sophie Julia; Christel Thauvin-Robinet; Lucie Gueneau; Jean-Benoit Courcet; Estelle Lopez; Katherine Holman; Marjolijn Renard; Henri Plauchu; Ghislaine Plessis; Julie De Backer; Anne Child; Gavin Arno; Laurence Duplomb; Patrick Callier; Bernard Aral; Pierre Vabres; Nadège Gigot; Eloisa Arbustini; Maurizia Grasso; Peter N Robinson; Cyril Goizet; Clarisse Baumann; Maja Di Rocco; Jaime Sanchez Del Pozo; Frédéric Huet; Guillaume Jondeau; Gwenaëlle Collod-Beroud; Christophe Beroud; Jeanne Amiel; Valérie Cormier-Daire; Jean-Baptiste Rivière; Catherine Boileau; Anne De Paepe; Laurence Faivre
Journal:  Am J Hum Genet       Date:  2012-10-25       Impact factor: 11.025

6.  Primary Cilia Direct Murine Articular Cartilage Tidemark Patterning Through Hedgehog Signaling and Ambulatory Load.

Authors:  Danielle Rux; Kimberly Helbig; Biao Han; Courtney Cortese; Eiki Koyama; Lin Han; Maurizio Pacifici
Journal:  J Bone Miner Res       Date:  2022-02-13       Impact factor: 6.390

7.  MiR-206 Attenuates Denervation-Induced Skeletal Muscle Atrophy in Rats Through Regulation of Satellite Cell Differentiation via TGF-β1, Smad3, and HDAC4 Signaling.

Authors:  Qiang Kai Huang; Hu-Yuan Qiao; Ming-Huan Fu; Gang Li; Wen-Bin Li; Zhi Chen; Jian Wei; Bing-Sheng Liang
Journal:  Med Sci Monit       Date:  2016-04-07

8.  The inhibitory roles of Ihh downregulation on chondrocyte growth and differentiation.

Authors:  Ang Deng; Hongqi Zhang; Minyu Hu; Shaohua Liu; Yuxiang Wang; Qile Gao; Chaofeng Guo
Journal:  Exp Ther Med       Date:  2017-11-07       Impact factor: 2.447

9.  Protective Effect of Triptolide against Glomerular Mesangial Cell Proliferation and Glomerular Fibrosis in Rats Involves the TGF- β 1/Smad Signaling Pathway.

Authors:  Yingjie Cao; Xinzhong Huang; Yaping Fan; Xiaolan Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-14       Impact factor: 2.629

10.  The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection.

Authors:  Claudia X Dominguez; Robert A Amezquita; Tianxia Guan; Heather D Marshall; Nikhil S Joshi; Steven H Kleinstein; Susan M Kaech
Journal:  J Exp Med       Date:  2015-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.